---
title: "Moderna to join Nasdaq-100, replacing Warner Bros. Discovery"
section: daily-news
published: 2026-10-02T04:12:03.640676+00:00
canonical: https://valorandventures.media/article/94a3e36b-2d77-4ff4-9e18-380e0f9c6a2f
publisher: "Valor & Ventures Media"
source: "Seeking Alpha"
source_url: https://seekingalpha.com/news/4649712-moderna-to-join-nasdaq-100-replacing-warner-bros-discovery?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
access: free
---

# Moderna to join Nasdaq-100, replacing Warner Bros. Discovery

## Executive Summary

In a notable realignment of one of the equity market's most prominent benchmarks, the biotechnology corporation Moderna is scheduled to join the Nasdaq-100 index. According to a report from Seeking Alpha, the company will take over the position currently held by media conglomerate Warner Bros. Discovery. This adjustment highlights the routine process of index reconstitution, which reflects ongoing changes in market representation and the relative scale of major listed enterprises. The transition marks a significant shift for the incoming constituent, Moderna, as it enters an index composed of the largest non-financial businesses listed on the Nasdaq stock market. Securing a spot in this benchmark is a widely recognized indicator of commercial scale and market presence. For the biotechnology sector, the addition of another prominent representative to the index underscores the industry's sustained profile within the broader corporate landscape. On the other side of the transition, the departure of Warner Bros. Discovery from the Nasdaq-100 illustrates the competitive nature of maintaining a position within major market indexes. Index providers regularly evaluate constituent companies against established criteria, including market capitalization and liquidity, to ensure the benchmark remains accurate. When a company is replaced, it highlights how shifts in market valuation can alter an organization's index standing relative to its peers. The mechanical implications of this change are particularly relevant for institutional investors and market participants. Financial products, such as exchange-traded funds and mutual funds that passively track the performance of the Nasdaq-100, must adjust their portfolios to mirror the updated index roster. This process typically requires these funds to acquire shares of the newly added company, Moderna, while selling down their positions in the departing firm, Warner Bros. Discovery. For the founders, corporate executives, and civic leaders within the Valor & Ventures Media audience, this index reconstitution serves as an instructive example of public market dynamics and capital allocation. The replacement of a major media entity by a prominent biotechnology firm offers a neutral reflection of evolving market priorities and sector trends. Monitoring these adjustments provides leadership teams with valuable context regarding how major investment benchmarks define and track corporate prominence in the modern business environment.

## Article

---
Seeking Alpha

---

Originally published by Seeking Alpha: https://seekingalpha.com/news/4649712-moderna-to-join-nasdaq-100-replacing-warner-bros-discovery?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news